Hypercalcemia (high calcium)
Last updated: 24 August 2026
Reviewed by: Specialist doctors from the Elfcare quality team
Feeling unusually thirsty, needing to urinate more often than normal, or persistent nausea and constipation with no clear explanation can be the body's way of signalling that calcium levels in the blood are higher than they should be. So can general tiredness or low mood that's been lingering for weeks or months.
Hypercalcemia is one of the most common electrolyte abnormalities found on routine blood testing, yet it is frequently overlooked because its symptoms are so non-specific. It ranges from a mild incidental finding to a serious medical emergency, and identifying the cause is critical because the two most common causes, excess parathyroid hormone and malignancy, have very different implications for long-term health.
Book a consultation now to test your health
What is hypercalcemia?
Calcium in the blood is tightly regulated by parathyroid hormone (PTH), vitamin D, and calcitonin. Normal serum calcium ranges from 2.2 to 2.6 mmol/L. Hypercalcemia is defined as a corrected serum calcium above 2.6 mmol/L.
As with hypocalcemia, total calcium must always be interpreted alongside albumin. Elevated albumin from dehydration can cause apparent hypercalcemia. Corrected or ionised calcium provides the true picture.
Severity determines clinical urgency:
Mild hypercalcemia (2.6 to 3.0 mmol/L) is often asymptomatic and commonly discovered incidentally.
Moderate hypercalcemia (3.0 to 3.5 mmol/L) causes symptoms including fatigue, nausea, and cognitive changes requiring investigation and treatment.
Severe hypercalcemia (above 3.5 mmol/L) is a medical emergency causing confusion, cardiac arrhythmias, and renal failure requiring immediate hospitalisation.
Symptoms of hypercalcemia
Hypercalcemia symptoms are often described as bones, groans, stones, and moans, reflecting the four main clinical domains affected. Common signs include:
Excessive thirst and frequent urination as the kidneys work to excrete excess calcium
Nausea, vomiting, constipation, and loss of appetite
Fatigue, weakness, and lethargy
Bone pain or tenderness from calcium being mobilised out of bones
Kidney stones from calcium crystallising in the urinary tract
Confusion, poor concentration, depression, or in severe cases altered consciousness
Muscle weakness and reduced reflexes
In severe cases: cardiac arrhythmias and renal failure requiring emergency treatment
Important: Calcium above 3.5 mmol/L with confusion, severe nausea, or cardiac symptoms requires immediate emergency medical care.
What causes hypercalcemia?
The vast majority of hypercalcemia cases are caused by one of two conditions. Identifying which one is the critical clinical question.
Overactive parathyroid glands: the most common cause. A small, usually harmless growth on these glands causes them to release too much hormone, which pulls calcium out of your bones and into your blood.
Malignancy: certain serious illnesses can cause calcium levels to rise quickly by affecting the bones or releasing specific proteins. This usually requires urgent medical attention.
Vitamin D toxicity: taking too much Vitamin D can cause the body to absorb more calcium than it can actually manage.
Specific inflammatory conditions: illnesses like sarcoidosis or tuberculosis can cause your body to produce extra active Vitamin D, which in turn raises calcium.
Lack of movement: prolonged bed rest or lack of weight-bearing activity can cause bones to release calcium into the bloodstream.
Medications: certain drugs, including lithium, some water tablets (diuretics), or overusing calcium-based antacids, can cause a spike.
Genetics: some people are born with a harmless genetic trait that keeps their calcium levels slightly higher than average without causing any health problems.
How is hypercalcemia detected?
Hypercalcemia is detected through blood testing, with supporting markers identifying the underlying cause.
Blood tests Elfcare's panel includes calcium alongside the key related markers:
Total calcium and albumin-corrected calcium: these are the primary markers. Corrected calcium provides the true calcium status independent of albumin levels.
Albumin: essential for accurate calcium interpretation, as dehydration and other conditions affecting albumin alter total calcium readings.
Phosphate: helps distinguish between gland issues (low levels) and other causes like vitamin D toxicity (high levels).
ALP: a marker of bone activity; high levels can indicate bone turnover or damage.
Magnesium: provides context on how your body is regulating minerals.
Creatinine and eGFR: assess kidney function, as hypercalcemia causes nephrogenic diabetes insipidus and progressive renal damage if untreated.
25-OH Vitamin D: identifies vitamin D toxicity as a cause and assesses baseline vitamin D status.
Total PSA: relevant when prostate cancer is a possible source of bone metastases causing hypercalcemia in men.
CRP: reflects systemic inflammation relevant to granulomatous conditions and malignancy-associated hypercalcaemia.
Abdominal MRI Elfcare's full body MRI provides a visual check that blood tests cannot. It directly images the neck to look for parathyroid growths, the kidneys for stones caused by calcium buildup, and the abdomen for any masses that might be driving the elevation.
Why early detection matters
Mild chronic hypercalcemia from primary hyperparathyroidism can persist for years causing progressive but silent kidney damage, bone density loss, and cardiovascular risk. When identified early, a parathyroid adenoma can be removed surgically with excellent long-term outcomes. Malignancy-associated hypercalcemia identified early allows for treatment of the primary cancer before severe metabolic complications develop. Kidney stones, cognitive decline, and irreversible renal damage from undetected chronic hypercalcemia are all preventable with early identification and management.
How Elfcare can help
Elfcare's blood panel covers calcium, albumin-corrected calcium, phosphate, ALP, magnesium, kidney function, vitamin D, and CRP, providing the complete picture of calcium status and the most likely underlying cause. The pattern of calcium, phosphate, and ALP together is particularly informative in distinguishing primary hyperparathyroidism from malignancy-associated hypercalcemia.
Our full body MRI images the neck region and kidneys, identifying parathyroid adenomas and kidney stones as structural correlates of hypercalcemia.
If our blood tests or MRI identify hypercalcemia or a suspicious finding, we take care of further diagnostics or refer you to the appropriate specialist.
Summary
Hypercalcemia is elevated blood calcium that disrupts kidney function, bone metabolism, nerve signalling, and heart rhythm, with consequences ranging from vague fatigue to life-threatening emergencies. It is most commonly caused by primary hyperparathyroidism or malignancy, two conditions with very different implications that a targeted blood panel can help distinguish. Elfcare's panel covers calcium, phosphate, ALP, magnesium, kidney function, and vitamin D, while our full body MRI images the parathyroid region and kidneys directly. Identifying hypercalcemia and its cause early is essential for protecting kidney function, bone density, and cardiovascular health over the long term.
Last updated: 24 August 2026
Reviewed by: Specialist doctors from the quality team at Elfcare
FAQ
-
Hypercalcaemia is a blood calcium level above 2.6 mmol/L. It is one of the most common electrolyte abnormalities found on routine blood testing. It ranges from mild and asymptomatic to a medical emergency. The two most common causes are primary hyperparathyroidism and malignancy, which have very different clinical implications and require different management.
-
Excessive thirst and urination, nausea, constipation, fatigue, bone pain, kidney stones, and cognitive changes including confusion and low mood. Severe hypercalcaemia above 3.5 mmol/L causes confusion, cardiac arrhythmias, and renal failure requiring immediate emergency treatment.
-
Primary hyperparathyroidism from a parathyroid adenoma is the most common outpatient cause. Malignancy is the most common cause in hospitalised patients. Vitamin D toxicity, granulomatous conditions, certain medications, and familial hypocalciuric hypercalcaemia are other causes.
-
A blood test measuring albumin-corrected calcium is the primary tool. Phosphate, ALP, vitamin D, kidney function, and CRP identify the underlying cause. The pattern of calcium, phosphate, and ALP together distinguishes hyperparathyroidism from malignancy-associated hypercalcaemia in most cases.
-
Yes. Elfcare's blood panel includes albumin-corrected calcium, phosphate, ALP, magnesium, vitamin D, and kidney function. Our full body MRI images the neck region and kidneys directly. If hypercalcaemia or a suspicious finding is identified, we take care of further diagnostics or refer you to the appropriate specialist.
-
Yes. Treatment depends on the cause and severity. Mild asymptomatic hyperparathyroidism is monitored or treated with parathyroid surgery, which is curative in the vast majority of cases. Malignancy-associated hypercalcaemia is treated with intravenous hydration, bisphosphonates, and treatment of the primary cancer. Vitamin D toxicity resolves with supplementation cessation. Severe acute hypercalcaemia requires emergency hospitalisation and intravenous treatment. Early identification and treatment prevent the progressive kidney damage, bone loss, and cardiovascular complications that untreated chronic hypercalcaemia causes.